Institutional Ownership Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS). We have compiled data on the 84 institutions that hold shares in the stock, with a total of 26.8 Million shares, which have been reported (via 13F filing form) to have a value of $78.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Sands Capital Ventures, LLC
Arlington, VA |
May 14, 2024 Q1 2024 |
3,417,075
shares
|
$10 Million
4.42% of portfolio
|
Q3 2021
New holding
|
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2024 Q1 2024 |
3,395,418
shares
|
$9.98 Million
0.0% of portfolio
|
Q1 2024
Added 1.09%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
2,629,541
shares
|
$7.73 Million
0.0% of portfolio
|
Q1 2024
Added 75.86%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2024 Q1 2024 |
2,300,059
shares
|
$6.76 Million
0.24% of portfolio
|
Q4 2023
Reduced 18.22%
|
|
|
Laurion Capital Management LP
New York, NY |
May 15, 2024 Q1 2024 |
1,895,023
shares
|
$5.57 Million
0.07% of portfolio
|
Q4 2023
Added 57.06%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
1,665,058
shares
|
$4.9 Million
0.0% of portfolio
|
Q1 2024
Reduced 9.49%
|
|
|
Knollwood Investment Advisory, LLC
Hunt Valley, MD |
May 14, 2024 Q1 2024 |
1,628,510
shares
|
$4.79 Million
1.19% of portfolio
|
Q3 2023
Reduced 2.98%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
1,098,276
shares
|
$3.23 Million
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
May 15, 2024 Q1 2024 |
939,603
shares
|
$2.76 Million
0.02% of portfolio
|
Q1 2024
Added 28.15%
|
|
|
Jane Street Group, LLC
New York, NY |
May 15, 2024 Q1 2024 |
600,255
shares
|
$1.76 Million
0.0% of portfolio
|
Q1 2024
Reduced 0.72%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2024 Q1 2024 |
576,657
shares
|
$1.7 Million
0.32% of portfolio
|
Q1 2024
Reduced 4.45%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
May 15, 2024 Q1 2024 |
560,000
shares
|
$1.65 Million
0.01% of portfolio
|
Q1 2024
Reduced 0.78%
|
|
|
Pathstone Holdings, LLC
Englewood, NJ |
May 13, 2024 Q1 2024 |
480,181
shares
|
$1.41 Million
0.01% of portfolio
|
Q1 2024
Added 0.22%
|
|
|
Pathstone Family Office, LLC
Englewood, NJ |
Nov 08, 2023 Q3 2023 |
478,790
shares
|
$1.41 Million
0.01% of portfolio
|
Q2 2023
Reduced 2.45%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
458,484
shares
|
$1.35 Million
0.01% of portfolio
|
Q1 2024
Reduced 18.35%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
317,904
shares
|
$934,637
0.0% of portfolio
|
Q1 2024
Added 177.08%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
285,139
shares
|
$838,308
0.0% of portfolio
|
Q1 2024
Added 7.76%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
May 16, 2024 Q1 2024 |
266,435
shares
|
$783,318
0.14% of portfolio
|
Q1 2024
Reduced 15.49%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 07, 2024 Q1 2024 |
265,843
shares
|
$781,578
0.0% of portfolio
|
Q1 2024
Reduced 46.81%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
246,895
shares
|
$725,871
0.12% of portfolio
|
Q4 2023
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2024 Q1 2024 |
217,000
shares
|
$637,980
0.0% of portfolio
|
Q1 2024
Added 67.31%
|
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
189,697
shares
|
$557,709
0.0% of portfolio
|
Q1 2024
Reduced 23.54%
|
|
|
Man Group PLC
London, X0 |
May 15, 2024 Q1 2024 |
187,585
shares
|
$551,499
0.0% of portfolio
|
Q1 2024
Added 29.7%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2024 Q1 2024 |
177,901
shares
|
$523,028
0.0% of portfolio
|
Q1 2024
Reduced 27.21%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 14, 2024 Q1 2024 |
167,588
shares
|
$492,708
0.0% of portfolio
|
Q1 2024
Added 89.1%
|
|